Editorial: Community series in novel insights into immunotherapy targeting tumor microenvironment in ovarian cancer: volume II

An Tong; Hai-Tao Wang; Xia-Wei Wei; Xiao Liang

doi:10.3389/fimmu.2023.1338119

Editorial: Community series in novel insights into immunotherapy targeting tumor microenvironment in ovarian cancer: volume II

Front Immunol. 2023 Nov 29:14:1338119. doi: 10.3389/fimmu.2023.1338119. eCollection 2023.

Authors

An Tong¹, Hai-Tao Wang², Xia-Wei Wei³, Xiao Liang¹

Affiliations

¹ Department of Gynecology and Obstetrics, Key Laboratory of Obstetrics & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province, West China Second University Hospital, Sichuan University, ChengDu, Sichuan, China.
² Thoracic Surgery Branch, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, United States.
³ Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

No abstract available

Keywords: bioinformatics analysis; cell therapy; immunotherapy; ovarian cancer; tumor immune microenvironment.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Female
Humans
Immunotherapy
Ovarian Neoplasms* / pathology
Ovarian Neoplasms* / therapy
Tumor Microenvironment*

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was funded by the Natural Science Foundation of Sichuan (No. 2022NSFSC1531 and No.2022NSFSC0206), the Science and Technology Development Fund of Macau (FDCT/0043/2021/A1), and the Dr. Stanley Ho Medical Development Foundation (SHMDF-VSEP/2022/002).